JP2008502695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008502695A5 JP2008502695A5 JP2007516652A JP2007516652A JP2008502695A5 JP 2008502695 A5 JP2008502695 A5 JP 2008502695A5 JP 2007516652 A JP2007516652 A JP 2007516652A JP 2007516652 A JP2007516652 A JP 2007516652A JP 2008502695 A5 JP2008502695 A5 JP 2008502695A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- asp
- sequence
- response
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58025404P | 2004-06-15 | 2004-06-15 | |
| US60/580,254 | 2004-06-15 | ||
| PCT/US2005/021004 WO2005122739A2 (en) | 2004-06-15 | 2005-06-15 | Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008502695A JP2008502695A (ja) | 2008-01-31 |
| JP2008502695A5 true JP2008502695A5 (enExample) | 2008-03-27 |
| JP4825797B2 JP4825797B2 (ja) | 2011-11-30 |
Family
ID=35510217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007516652A Expired - Fee Related JP4825797B2 (ja) | 2004-06-15 | 2005-06-15 | 回旋糸状虫の天然産物のアジュバント性及び免疫増強特性 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7700120B2 (enExample) |
| EP (1) | EP1768696B1 (enExample) |
| JP (1) | JP4825797B2 (enExample) |
| KR (1) | KR20070048140A (enExample) |
| CN (1) | CN101151049A (enExample) |
| AU (1) | AU2005254087B2 (enExample) |
| BR (1) | BRPI0512173A (enExample) |
| CA (1) | CA2570218C (enExample) |
| ES (1) | ES2549669T3 (enExample) |
| IL (1) | IL180079A (enExample) |
| NZ (1) | NZ552583A (enExample) |
| WO (1) | WO2005122739A2 (enExample) |
| ZA (1) | ZA200700457B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4683740B2 (ja) * | 2001-02-15 | 2011-05-18 | 明治乳業株式会社 | 炎症に伴う症状の軽減剤 |
| CN101151049A (zh) * | 2004-06-15 | 2008-03-26 | 纽约血液中心有限公司 | 旋盘尾丝虫的天然产物的佐剂和免疫加强性能 |
| EP2485758A1 (en) | 2009-10-09 | 2012-08-15 | New York Blood Center, Inc. | Immunopotentiator-linked oligomeric influenza immunogenic compositions |
| CN103554241B (zh) * | 2013-10-25 | 2015-04-15 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种具有免疫调节活性的重组蛋白asppr及应用 |
| CN108367069B (zh) | 2015-12-14 | 2022-08-23 | 宏观基因有限公司 | 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法 |
| JP6256460B2 (ja) | 2015-12-28 | 2018-01-10 | 日亜化学工業株式会社 | チオガレート系蛍光体の製造方法 |
| WO2017173369A1 (en) | 2016-04-01 | 2017-10-05 | New York Blood Center, Inc. | Biomakers and immunogenic compositions for filarial parasites |
| JP6561976B2 (ja) | 2016-12-02 | 2019-08-21 | 日亜化学工業株式会社 | チオガレート系蛍光体の製造方法、発光装置の製造方法、チオガレート系蛍光体及び発光装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4370265A (en) * | 1974-10-22 | 1983-01-25 | Agence Nationale De Valorisation | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
| US5169840A (en) | 1991-03-27 | 1992-12-08 | Nobipols Forskningsstiftelse | Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation |
| US20020102273A1 (en) * | 1995-08-08 | 2002-08-01 | Robert B. Grieve | Use of alphavirus expression vectors to produce parasite anitgens |
| US5789194A (en) * | 1995-05-23 | 1998-08-04 | Heska Corporation | Parasitic helminth venom allergen antigen 5-like genes and proteins |
| US6682746B2 (en) | 1995-09-21 | 2004-01-27 | Kristina J. Hennessy | Adjuvanted vaccine which is substantially free of non-host albumin |
| CA2289040A1 (en) | 1997-05-01 | 1998-11-05 | Protechtion Unlimited, Inc. | Nerve growth factor as a vaccine adjuvant |
| FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| CA2330610A1 (en) | 1998-05-07 | 1999-11-11 | Corixa Corporation | Adjuvant composition and methods for its use |
| FR2790959B1 (fr) * | 1999-03-15 | 2003-06-27 | Pf Medicament | Utilisation de fractions membranaires bacteriennes a effet adjuvant, leurs procedes de preparation et composition pharmaceutique les contenant |
| DE60012711T2 (de) | 1999-03-26 | 2005-08-18 | Vical, Inc., San Diego | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe |
| US6649170B1 (en) | 1999-05-12 | 2003-11-18 | Statens Serum Institut | Adjuvant combinations for immunization composition and vaccines |
| US6635261B2 (en) | 1999-07-13 | 2003-10-21 | Wyeth Holdings Corporation | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
| US6537552B1 (en) | 1999-10-19 | 2003-03-25 | Iowa State University Research Foundation | Vaccine adjuvant |
| US6723322B1 (en) * | 2000-04-03 | 2004-04-20 | New York Blood Center, Inc. | Angiogenic Onchocerca volvulus proteins and uses thereof |
| EP1377299A4 (en) * | 2001-03-19 | 2009-11-11 | Intercell Usa Inc | TRANSCUTANE IMMUNOSTIMULATION |
| US6676958B2 (en) | 2001-06-19 | 2004-01-13 | Advanced Bioadjuvants, Llc | Adjuvant composition for mucosal and injection delivered vaccines |
| GB0123756D0 (en) * | 2001-10-03 | 2001-11-21 | King S College London | A novel chaperone-type of adjuvant for vaccination - Basic 1 |
| CN101151049A (zh) * | 2004-06-15 | 2008-03-26 | 纽约血液中心有限公司 | 旋盘尾丝虫的天然产物的佐剂和免疫加强性能 |
-
2005
- 2005-06-15 CN CNA2005800270870A patent/CN101151049A/zh active Pending
- 2005-06-15 US US11/153,222 patent/US7700120B2/en active Active
- 2005-06-15 ZA ZA200700457A patent/ZA200700457B/xx unknown
- 2005-06-15 EP EP05790464.1A patent/EP1768696B1/en not_active Expired - Lifetime
- 2005-06-15 JP JP2007516652A patent/JP4825797B2/ja not_active Expired - Fee Related
- 2005-06-15 WO PCT/US2005/021004 patent/WO2005122739A2/en not_active Ceased
- 2005-06-15 CA CA2570218A patent/CA2570218C/en not_active Expired - Lifetime
- 2005-06-15 NZ NZ552583A patent/NZ552583A/en not_active IP Right Cessation
- 2005-06-15 ES ES05790464.1T patent/ES2549669T3/es not_active Expired - Lifetime
- 2005-06-15 BR BRPI0512173-6A patent/BRPI0512173A/pt not_active IP Right Cessation
- 2005-06-15 AU AU2005254087A patent/AU2005254087B2/en not_active Ceased
- 2005-06-15 KR KR20067027886A patent/KR20070048140A/ko not_active Withdrawn
-
2006
- 2006-12-14 IL IL180079A patent/IL180079A/en active IP Right Grant
-
2009
- 2009-03-23 US US12/409,399 patent/US9255140B2/en not_active Expired - Fee Related
-
2010
- 2010-02-18 US US12/708,095 patent/US9017699B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adar et al. | A universal epitope-based influenza vaccine and its efficacy against H5N1 | |
| JP2008530245A5 (enExample) | ||
| Manocha et al. | Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target | |
| ES2741729T3 (es) | Vectores y construcciones de liberación de antígenos de virus de la gripe | |
| ES2714383T3 (es) | Vacuna TB contra la tuberculosis para impedir la reactivación | |
| JP2006020648A5 (enExample) | ||
| JP2008526764A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2009544614A5 (enExample) | ||
| NZ601345A (en) | Combination adjuvant formulation | |
| JP2009515831A5 (enExample) | ||
| WO2008026225A3 (en) | A vaccine for chikungunya virus infection | |
| MXPA02005639A (es) | Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico. | |
| JP2009504654A5 (enExample) | ||
| Pitcovski et al. | Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine | |
| AU3847801A (en) | Proteosome influenza vaccine | |
| JP2010532656A5 (enExample) | ||
| CN101745104A (zh) | 含有复合佐剂的结核亚单位疫苗 | |
| JP2002533125A5 (enExample) | ||
| CN116348101A (zh) | 嵌合腺病毒载体 | |
| CA2832022C (en) | Pharmaceutical compositions for preventing and/or treating an hiv disease in humans | |
| JP2010506926A5 (enExample) | ||
| CN102665422B (zh) | 通过口服施用重组乳酸乳球菌微型胶囊的免疫保护方法 | |
| JP2009522368A5 (enExample) | ||
| JP2012526519A5 (enExample) |